Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 5 20 SULFITE FREE IN DEXTROSE 20 IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 5 20 SULFITE FREE IN DEXTROSE 20 IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER vs PERIKABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Parenteral nutrition formulation providing amino acids (synthetic crystalline L-amino acids), dextrose (carbohydrate calories), and electrolytes. Amino acids support protein synthesis and nitrogen balance; dextrose provides calories to prevent catabolism.
Perikabiven provides a balanced mixture of amino acids, electrolytes, dextrose, and lipids for parenteral nutrition. Amino acids serve as building blocks for protein synthesis, dextrose provides glucose for energy, and lipids supply essential fatty acids and a concentrated energy source. Electrolytes maintain osmotic balance and support biochemical reactions.
Intravenous use only. Typical adult dose for maintenance or replacement is 1 to 2 L per day, administered via central or peripheral vein. Contains dextrose 20% with 5% amino acids representing 170 kcal/L from dextrose and 40 g protein/L. Rate of infusion depends on metabolic and clinical needs, generally not to exceed 4 mg/kg/min dextrose.
Intravenous administration: usual adult dose is 1.5 to 2.0 g amino acids per kg per day, corresponding to 25-30 mL/kg/day of Perikabiven, with a maximum infusion rate of 2.5 mL/kg/hour.
None Documented
None Documented
Not applicable as a fixed drug; the components have varying half-lives: amino acids ~1-2 hours, dextrose ~1-2 hours, electrolytes follow physiological kinetics.
Amino acids: ~0.5-1 hour (rapid clearance due to metabolic incorporation and urinary elimination). Lipids: terminal elimination half-life of ~30 minutes to 1.5 hours for triglycerides, with longer half-life for essential fatty acids (days to weeks due to incorporation into cell membranes). Clinical context: rapid clearance from plasma with continuous infusion.
Renal (primarily as urea, glucose, electrolytes); >90% of infused nitrogen excreted as urea in urine; glucose is metabolized or excreted renally if hyperglycemic; electrolytes follow renal excretion.
Renal (primarily as ammonium and urea) and biliary (fecal loss of unabsorbed lipids). The amino acids, dextrose, and electrolytes are eliminated via renal excretion; lipids are metabolized and eliminated as CO2 and water. Approximately 20-30% of the lipid dose is excreted renally as metabolites, with <5% excreted unchanged.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition